Imageens is excited to announce its strategic partnership with Mieux.
This collaboration aims to elevate cardiovascular health assessment through the integration of Imageens’ innovative solution, CardioInspect, into cardiovascular check-up program, “Mieux”.
“Mieux” has already established itself as a gold standard in comprehensive cardiovascular check-ups, and the integration of CardioInspect will further enhance its capabilities, providing patients with unprecedented insights into their heart health and fostering a proactive approach to disease prevention.
“We are thrilled to partner with “Mieux” to bring CardioInspect to their check-up program,” stated the CEO of Imageens. “This collaboration marries Imageens’ expertise in cardiovascular imaging with Prevention Clinic ICP’s commitment to proactive healthcare, ensuring that patients receive the most advanced and comprehensive cardiovascular health assessment available.”
“Mieux” expressed enthusiasm about the partnership: “The integration of CardioInspect aligns perfectly with our mission to provide our patients with the most advanced and accurate health assessments available. This collaboration exemplifies our commitment to staying at the forefront of preventive healthcare.”
Imageens is a Paris-based Healthtech company founded in 2017, focusing on the prevention and early diagnosis of cardiovascular diseases (CVD). Since its inception, Imageens has been immersed in international DeepTech and established with the goal of developing market-ready medical image processing software based on over 10 years of technical and clinical research conducted by world-class research institutions such as Sorbonne Université, the AP-HP, and Johns Hopkins.
From the outset, Imageens has demonstrated its capability to harness advanced AI in creating cutting-edge medical software. This innovation has earned recognition through several prestigious French innovation competitions and multiple innovation labels.
Today, Imageens leads the charge in the rapidly growing field of AI in cardiovascular health and medical imaging. The company possesses the world’s most clinically validated technology for analyzing arterial function through MRI, deploying this technology alongside other AI components to revolutionize treatment decisions in cardiovascular health and beyond. Learn more at www.Imageens.com.